Ophthalmic Business

The K8 implant, a first-in-class dual inflammasome inhibitor, demonstrated positive efficacy and safety at 3 months in five patients with bilateral geographic atrophy, according to a press release from Inflammasome Therapeutics.

City Therapeutics and Bausch + Lomb have entered into a strategic collaboration focused on the development of an RNA interference-based treatment for geographic atrophy, according to a press release.

Canyon Labs announced the strategic acquisition of iuvo BioScience’s laboratory services and scientific consulting divisions, according to a press release.

Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.

Cencora completed its acquisition of Retina Consultants of America, according to a press release.

CHICAGO — In this Healio Video Perspective from the AAO meeting, John Saharek, CEO and president of ImprimisRx, previews two recently launched ophthalmic surgery products.

Healio’s top ophthalmology blogs from 2024 covered topics including dry eye and photophobia, the latest in IOL technology and the use of AI for marketing.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology.

EssilorLuxottica announced the acquisition of Espansione Group, an Italian company that specializes in the design and manufacturing of noninvasive medical devices for eye care, according to a press release.

Tenpoint Therapeutics and Visus Therapeutics announced the completion of their merger, according to a press release.